LLY · News · 20260916N

Lilly TuneLab Collaboration

ELI LILLY & Co · 2026-09-16 · Importance 28 · Surprise 42

Twist Bioscience announced an agreement with Lilly TuneLab on September 16, 2026. The collaboration gives Twist a data-pipeline role within Lilly TuneLab, Lilly’s collaborative artificial-intelligence and machine-learning drug-discovery platform. The reporting did not disclose the agreement’s financial value, duration, jurisdictions, or milestone payments.

Key facts

• Eli Lilly & Co's Lilly TuneLab had an agreement announced with Twist Bioscience Corporation on Wednesday. source
• Lilly TuneLab is a collaborative AI/ML drug discovery platform created by Eli Lilly and Co. source